What on earth is going on over at the FDA?
Recently, they have been facing some very difficult issues regarding narcotic pain medications. In particular, as pointed out by ACSH s Dr. Josh Bloom in his December 2nd op-ed in The New York Post, they just enacted a rule change that, ostensibly in the interest of combating drug abuse, will make it much more difficult for patients with legitimate need for drugs to control moderate-to-severe pain to get the medicines they need a seriously flawed idea.
